On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Bristol-Myers Squibb (Canada)

InstitutionResearch output, impact & collaborations

Bristol-Myers Squibb (Canada) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Bristol-Myers Squibb (Canada)?

ScholarIQrecord summary

Bristol-Myers Squibb (Canada) is a research organisation in Montreal, CA. OpenAlex records 216 works and 12,477 citations for it. 53 researchers list it as their most recent affiliation.

How many works does Bristol-Myers Squibb (Canada) have?

ScholarIQindexed works

Bristol-Myers Squibb (Canada) has 216 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Bristol-Myers Squibb (Canada) →

How many citations does Bristol-Myers Squibb (Canada) have?

ScholarIQcitation count

Bristol-Myers Squibb (Canada) has 12,477 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Bristol-Myers Squibb (Canada) →

How many researchers are at Bristol-Myers Squibb (Canada)?

ScholarIQresearcher count

Bristol-Myers Squibb (Canada) has 53 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Bristol-Myers Squibb (Canada)?

ScholarIQavg h-index

Bristol-Myers Squibb (Canada) has an average h-index of 4 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Bristol-Myers Squibb (Canada)?

ScholarIQror

The ROR for Bristol-Myers Squibb (Canada) is on the source record.

Open the ROR →

What is the OpenAlex record for Bristol-Myers Squibb (Canada)?

ScholarIQopenalex

The OpenAlex for Bristol-Myers Squibb (Canada) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Bristol-Myers Squibb (Canada)?

ScholarIQtop researchers by citations

D. Tomaras · Health Systems, Economic Evaluations, Quality of Life

27 works66 citations

What are the most-cited papers on Bristol-Myers Squibb (Canada)?

ScholarIQmost cited works

Non-small cell lung cancer with <i>EGFR</i> exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes

C.S. Kwon, Huamao Mark Lin, Victoria Crossland, Eric N. Churchill, Eileen Curran, Anna Forsythe, D. Tomaras, Sai‐Hong Ignatius Ou

Current Medical Research and Opinion. 202235 Citations

Jatin J. Shah, Sharon Shacham, Michael Kauffman, Patrick Daniele, D. Tomaras, Gabriel Tremblay, Olivier Casasnovas, Marie Maerevoet, Josée M. Zijlstra, George Follows, Joost S.P. Vermaat, Nagesh Kalakonda, André Goy, Sylvain Choquet, Éric Van Den Neste, Brian T. Hill, Catherine Thiéblemont, Federica Cavallo, Fátima De la Cruz, John Kuruvilla, Nada Hamad, Réda Bouabdallah, Ulrich Jäger, Paolo F. Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan‐Manuel Sancho, Michael Schuster, Miklós Egyed, Fritz Offner, T. Vasilakopoulos, Priyanka Samal, Ágnes Nagy, Matthew Ku, Miguel Canales

Future Oncology. 202111 CitationsOPEN ACCESS

1362P Clinical and real-world outcomes in patients with epidermal growth factor receptor (EGFR) exon 20 insertions in non-small cell lung cancer (NSCLC): A meta-analysis

D. Tomaras, Hongcao Lin, Anna Forsythe, Victoria Crossland, S-H.I. Ou

Annals of Oncology. 20206 Citations

Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

Gabriel Tremblay, D. Tomaras, E Strati, Anna Forsythe

Journal of health economics and outcomes research. 20214 CitationsOPEN ACCESS

Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis

Gabriel Tremblay, Qayyim Said, Beilei Cai, Shan Ashton Garib, D. Tomaras, Anna Forsythe, Anuja Roy

Blood. 20183 Citations

How much of the research on Bristol-Myers Squibb (Canada) is open access?

ScholarIQopen access share

30%OPEN ACCESS

Gold

20%

Green

Hybrid

10%

Bronze

Closed

70%